サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1628867

バイオコンジュゲーションの世界市場：種類別・手法別・提供内容別・バイオコンジュゲーションの種類別・用途別・治療領域別・エンドユーザー別・国別・地域別 - 産業分析、市場規模・シェア、将来予測 (2024年～2032年)

Bioconjugation Market, By Type, By Technique, By Offering, By Bioconjugation Type, By Application, By Therapeutic Area, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 398 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
バイオコンジュゲーションの世界市場：種類別・手法別・提供内容別・バイオコンジュゲーションの種類別・用途別・治療領域別・エンドユーザー別・国別・地域別 - 産業分析、市場規模・シェア、将来予測 (2024年～2032年)
出版日: 2024年11月02日
発行: AnalystView Market Insights
ページ情報: 英文 398 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

バイオコンジュゲーションの市場規模は2023年に51億2,232万米ドルとなり、2024年から2032年にかけて15.2%のCAGRで拡大

バイオコンジュゲーションの市場力学

抗体薬物複合体 (ADC) の需要増加が市場需要を促進

バイオコンジュゲーションの重要な用途であるADCは、標的を絞ったがん治療により高い成長が見込まれています。また、慢性疾患の治療におけるバイオ治療薬の用途拡大がバイオコンジュゲーション研究を後押ししています。しかし、高度なバイオコンジュゲーション技術は多額の資金を必要とするため、中小企業の参入は限られています。逆に、新規のコンジュゲーションツールは効率を向上させ、診断や個別化医療への幅広い応用を促しています。さらに、資金調達の増加により研究開発が支援され、バイオコンジュゲーション市場成長の新たな道が開けています。

バイオコンジュゲーション市場：主な考察

リサーチアナリストの分析によると、世界市場は予測期間 (2024～2032年) に約15.2%のCAGRで毎年成長すると予測されています。

種類別に見ると、天然バイオコンジュゲーションが2023年に最大市場シェアを示すと予測されました。

手法別に見ると、アミド結合形成が2023年に主要なタイプでした。

提供内容別に見ると、2023年にはサービスが主要タイプでした。

バイオコンジュゲーションの種類別に見ると、2023年にはタンパク質バイオコンジュゲーションが主要な種類でした。

用途別に見ると、2023年の主要タイプは治療薬でした。

地域別では、北米が2023年の売上高でトップでした。

バイオコンジュゲーション市場：セグメンテーション分析

世界のバイオコンジュゲーション市場は、種類、手法、提供内容、バイオコンジュゲーションの種類、用途、治療領域、エンドユーザー、地域に基づいて区分されます。

バイオコンジュゲート市場は、合成バイオコンジュゲートと天然バイオコンジュゲートの2つに分類されます。天然バイオコンジュゲート分野は、生物製剤や医薬品開発に広く応用され、生物学的システムに高い特異性と適合性を提供することから、バイオコンジュゲーション市場を独占すると予想されます。

市場は手法によって、アミド結合形成、クリックケミストリー、バイオ直交反応、酵素法、チオール-マレイミドカップリングの5つに分類されます。アミド結合形成分野が市場を独占しており、予測期間中もその優位性を維持するとみられます。これは、治療・診断用途の生体分子の連結に広く使用されているためです。その安定性と効率性により、広く好まれています。

バイオコンジュゲーション市場：地域別分析

地域的には、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカの各地域に広がっています。これらの地域は、ビジネスをもたらす国によってさらに分けられます。

バイオコンジュゲーション市場：競合情勢

標的治療やドラッグデリバリーの革新に対する需要の高まりに後押しされ、バイオコンジュゲーション市場では、新規技術の研究開発投資、用途拡大のための提携、高度なコンジュゲーション技術による製品の差別化などの戦略が見られます。企業は、より優れた有効性と安全性を実現するために、リンカーやペイロードの最適化に注力しています。さらに、バイオ医薬品や診断薬における需要の高まりに対応するため、規制への対応や製造能力の拡大も重視されています。これらの戦略は総合的に市場競争力を高め、次世代治療ソリューションの開発を可能にします。

目次

第1章 バイオコンジュゲーション市場の概要

  • 調査範囲
  • 市場推定期間

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 バイオコンジュゲーションの主な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 バイオコンジュゲーション市場：産業分析

  • PEST分析
  • ポーターのファイブフォース分析
  • 市場成長の見通し：マッピング
  • 規制体制の分析

第5章 バイオコンジュゲーション市場：高まる地政学的緊張の影響

  • COVID-19パンデミックの影響
  • ロシア・ウクライナ戦争の影響
  • 中東紛争の影響

第6章 バイオコンジュゲーションの市場情勢

  • バイオコンジュゲーションの市場シェア分析 (2023年)
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 バイオコンジュゲーション市場：種類別

  • 概要
    • セグメントシェア分析：種類別
    • 天然バイオコンジュゲート
    • 合成バイオコンジュゲート

第8章 バイオコンジュゲーション市場：手法別

  • 概要
    • セグメントシェア分析：手法別
    • アミド結合の形成
    • クリックケミストリー
    • バイオ直交反応
    • チオール-マレイミドカップリング
    • 酵素法

第9章 バイオコンジュゲーション市場：提供内容別

  • 概要
    • セグメントシェア分析：提供内容別
    • 試薬・キット
    • サービス
      • ADCプロセス開発
      • 医薬品原料製造
      • 分析開発
      • 初期開発バイオコンジュゲートサービス
      • 標的剤またはキャリアタンパク質サービス
      • ペイロードとリンカーの製造

第10章 バイオコンジュゲーション市場：バイオコンジュゲーションの種類別

  • 概要
    • セグメントシェア分析：バイオコンジュゲーションの種類別
    • オリゴヌクレオチドバイオコンジュゲーション
      • 一本鎖オリゴヌクレオチド
      • 二本鎖オリゴヌクレオチド
    • ポリマーバイオコンジュゲーション
    • ペプチドバイオコンジュゲーション
    • タンパク質バイオコンジュゲーション

第11章 バイオコンジュゲーション市場：用途別

  • 概要
    • セグメントシェア分析：用途別
    • 診断
    • 治療
      • ワクチン
      • モノクローナル抗体
      • 抗生物質
    • 研究開発

第12章 バイオコンジュゲーション市場：治療領域別

  • 概要
    • セグメントシェア分析：治療領域別
    • 感染症
    • 免疫学
    • 心血管疾患
    • 腫瘍学

第13章 バイオコンジュゲーション市場：エンドユーザー別

  • 概要
    • セグメントシェア分析：エンドユーザー別
    • バイオテクノロジー企業
    • 学術・研究機関
    • 製薬企業
    • CRO (医薬品開発業務受託機関)

第14章 バイオコンジュゲーション市場：地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋 (APAC)
    • 概要
    • アジア太平洋の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第15章 主要ベンダー分析：バイオコンジュゲーション業界

  • 競合ダッシュボード
    • 競合ベンチマーク
    • 競合ポジショニング
  • 企業プロファイル
    • AbbVie Inc.
    • Abcam plc
    • Abzena Limited
    • Agilent Technologies, Inc.
    • AstraZeneca PLC
    • Biocon Limited
    • Bio-Techne Corporation
    • Boehringer Ingelheim GmbH
    • Charles River Laboratories International, Inc.
    • Bristol-Myers Squibb Company
    • Eli Lilly and Company
    • GlaxoSmithKline plc
    • F. Hoffmann-La Roche AG
    • Innovagen AB
    • Lonza Group AG
    • Johnson &Johnson Services Inc.
    • Merck KGaA
    • Sanofi SA
    • Pfizer Inc.
    • Sartorius AG
    • Sutro Biopharma, Inc.
    • Sorrento Therapeutics, Inc.
    • Thermo Fisher Scientific Inc.
    • WuXi AppTec Co., Ltd.
    • Others

第16章 AnalystViewの全方位的分析

目次
Product Code: ANV4390

REPORT HIGHLIGHT

Bioconjugation market size was valued at USD 5,122.32 Million in 2023, expanding at a CAGR of 15.2% from 2024 to 2032.

Bioconjugation is the process of chemically linking two biomolecules, such as proteins, antibodies, or nucleic acids, to enhance their functionality or specificity. This technique is widely applied in drug development, diagnostics, and imaging. By attaching therapeutic agents or markers to biomolecules, bioconjugation enables targeted delivery, improved stability, and reduced side effects. It is a cornerstone in developing antibody-drug conjugates, biosensors, and personalized medicine, significantly advancing biotherapeutics and biomedical research.

Bioconjugation Market- Market Dynamics

Rising demand for antibody-drug conjugates (ADC) growth to propel market demand

ADCs, a critical application of bioconjugation, are expected to witness strong growth due to their targeted cancer therapies. Besides, expanding applications of biotherapeutics in treating chronic diseases boost bioconjugation research. However, advanced bioconjugation techniques demand significant financial investment, limiting accessibility for smaller firms. On the contrary, novel conjugation tools improve efficiency, encouraging broader applications in diagnostics and personalized medicine. Furthermore, increasing funding supports R&D, creating new avenues for bioconjugation market growth.

Bioconjugation Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 15.2% over the forecast period (2024-2032)

Based on type segmentation, natural bioconjugations was predicted to show maximum market share in the year 2023

Based on technique segmentation, amide bond formation was the leading type in 2023

Based on offering segmentation, services were the leading type in 2023

Based on bioconjugation type segmentation, protein bioconjugation was the leading type in 2023

Based on application segmentation, therapeutic was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Bioconjugation Market- Segmentation Analysis:

The Global Bioconjugation Market is segmented on the basis of Type, Technique, Offering, Bioconjugation Type, Application, Therapeutic Area, End User, and Region.

The market is divided into two categories based on Type: synthetic bioconjugates and natural bioconjugates. The natural bioconjugates segment is expected to dominate the bioconjugation market due to its widespread application in biologics and drug development, offering high specificity and compatibility with biological systems.

The market is divided into five categories based on Technique: amide bond formation, click chemistry, bio-orthogonal reactions, and enzymatic methods, and thiol-maleimide coupling. The amide bond formation sector dominates the market and is likely to maintain its dominance during the forecast period. This is due to its extensive use in linking biomolecules for therapeutic and diagnostic applications. Its stability and efficiency make it widely preferred.

Bioconjugation Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Bioconjugation Market- Competitive Landscape:

Driven by the increasing demand for targeted therapies and drug delivery innovations, the bioconjugation market sees strategies like R&D investments for novel technologies, partnerships to expand applications, and product differentiation through advanced conjugation techniques. Companies focus on optimizing linkers and payloads for better efficacy and safety. Additionally, the market emphasizes regulatory compliance and scaling manufacturing capabilities to meet growing demands in biopharmaceuticals and diagnostics. These strategies collectively enhance market competitiveness and enable the development of next-generation therapeutic solutions.

Recent Developments:

In November 2024, Lonza announced that it is expanding its bioconjugation facility in Visp, Switzerland, adding two 1,200 L manufacturing suites and infrastructure, creating 200 jobs. Operations are expected to begin in 2028.

In March 2024, Abzena announced that it is expanding its Bristol, PA bioconjugate manufacturing site with a $5 million investment in new equipment, upgraded facilities, and enhanced laboratory space, boosting biopharmaceutical program capacity.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL BIOCONJUGATION MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • AbbVie Inc.
  • Abcam plc
  • Abzena Limited
  • Agilent Technologies, Inc.
  • AstraZeneca PLC
  • Biocon Limited
  • Bio-Techne Corporation
  • Boehringer Ingelheim GmbH
  • Charles River Laboratories International, Inc.
  • Bristol-Myers Squibb Company
  • Eli Lilly and Company
  • GlaxoSmithKline plc
  • F. Hoffmann-La Roche AG
  • Innovagen AB
  • Lonza Group AG
  • Johnson & Johnson Services Inc.
  • Merck KGaA
  • Sanofi S.A.
  • Pfizer Inc.
  • Sartorius AG
  • Sutro Biopharma, Inc.
  • Sorrento Therapeutics, Inc.
  • Thermo Fisher Scientific Inc.
  • WuXi AppTec Co., Ltd.
  • Others

GLOBAL BIOCONJUGATION MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Natural Bioconjugates
  • Synthetic Bioconjugates

GLOBAL BIOCONJUGATION MARKET, BY TECHNIQUE- MARKET ANALYSIS, 2019 - 2032

  • Amide Bond Formation
  • Click Chemistry
  • Bio-orthogonal Reactions
  • Thiol-Maleimide Coupling
  • Enzymatic Methods

GLOBAL BIOCONJUGATION MARKET, BY OFFERING- MARKET ANALYSIS, 2019 - 2032

  • Reagents & Kits
  • Services
  • ADC Process Development
  • Drug Substance Manufacturing
  • Analytical Development
  • Early Development Bioconjugate Services
  • Targeting Agent or Carrier Protein Services
  • Payload & Linker Manufacturing

GLOBAL BIOCONJUGATION MARKET, BY BIOCONJUGATION TYPE- MARKET ANALYSIS, 2019 - 2032

  • Oligonucleotide Bioconjugation
  • Single-stranded Oligonucleotides
  • Double-stranded Oligonucleotides
  • Polymer Bioconjugation
  • Peptide Bioconjugation
  • Protein Bioconjugation

GLOBAL BIOCONJUGATION MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Diagnostics
  • Therapeutic
  • Vaccines
  • Monoclonal Antibodies
  • Antibiotics
  • Research & Development

GLOBAL BIOCONJUGATION MARKET, BY THERAPEUTIC AREA- MARKET ANALYSIS, 2019 - 2032

  • Infectious Diseases
  • Immunology
  • Cardiovascular Disorders
  • Oncology

GLOBAL BIOCONJUGATION MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Biotechnology Companies
  • Academic & Research Institutions
  • Pharmaceutical Companies
  • Contract Research Organizations

GLOBAL BIOCONJUGATION MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Bioconjugation Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Bioconjugation Market Snippet by Type
    • 2.1.2. Bioconjugation Market Snippet by Technique
    • 2.1.3. Bioconjugation Market Snippet by Offering
    • 2.1.4. Bioconjugation Market Snippet by Bioconjugation Type
    • 2.1.5. Bioconjugation Market Snippet by Application
    • 2.1.6. Bioconjugation Market Snippet by Therapeutic Area
    • 2.1.7. Bioconjugation Market Snippet by End User
    • 2.1.8. Bioconjugation Market Snippet by Country
    • 2.1.9. Bioconjugation Market Snippet by Region
  • 2.2. Competitive Insights

3. Bioconjugation Key Market Trends

  • 3.1. Bioconjugation Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Bioconjugation Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Bioconjugation Market Opportunities
  • 3.4. Bioconjugation Market Future Trends

4. Bioconjugation Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Bioconjugation Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Bioconjugation Market Landscape

  • 6.1. Bioconjugation Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Bioconjugation Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2023 & 2032 (%)
    • 7.1.2. Natural Bioconjugates
    • 7.1.3. Synthetic Bioconjugates

8. Bioconjugation Market - By Technique

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Technique, 2023 & 2032 (%)
    • 8.1.2. Amide Bond Formation
    • 8.1.3. Click Chemistry
    • 8.1.4. Bio-orthogonal Reactions
    • 8.1.5. Thiol-Maleimide Coupling
    • 8.1.6. Enzymatic Methods

9. Bioconjugation Market - By Offering

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Offering, 2023 & 2032 (%)
    • 9.1.2. Reagents & Kits
    • 9.1.3. Services
      • 9.1.3.1. ADC Process Development
      • 9.1.3.2. Drug Substance Manufacturing
      • 9.1.3.3. Analytical Development
      • 9.1.3.4. Early Development Bioconjugate Services
      • 9.1.3.5. Targeting Agent or Carrier Protein Services
      • 9.1.3.6. Payload & Linker Manufacturing

10. Bioconjugation Market - By Bioconjugation Type

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Bioconjugation Type, 2023 & 2032 (%)
    • 10.1.2. Oligonucleotide Bioconjugation
      • 10.1.2.1. Single-stranded Oligonucleotides
      • 10.1.2.2. Double-stranded Oligonucleotides
    • 10.1.3. Polymer Bioconjugation
    • 10.1.4. Peptide Bioconjugation
    • 10.1.5. Protein Bioconjugation

11. Bioconjugation Market - By Application

  • 11.1. Overview
    • 11.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 11.1.2. Diagnostics
    • 11.1.3. Therapeutic
      • 11.1.3.1. Vaccines
      • 11.1.3.2. Monoclonal Antibodies
      • 11.1.3.3. Antibiotics
    • 11.1.4. Research & Development

12. Bioconjugation Market - By Therapeutic Area

  • 12.1. Overview
    • 12.1.1. Segment Share Analysis, By Therapeutic Area, 2023 & 2032 (%)
    • 12.1.2. Infectious Diseases
    • 12.1.3. Immunology
    • 12.1.4. Cardiovascular Disorders
    • 12.1.5. Oncology

13. Bioconjugation Market - By End User

  • 13.1. Overview
    • 13.1.1. Segment Share Analysis, By End User, 2023 & 2032 (%)
    • 13.1.2. Biotechnology Companies
    • 13.1.3. Academic & Research Institutions
    • 13.1.4. Pharmaceutical Companies
    • 13.1.5. Contract Research Organizations

14. Bioconjugation Market- By Geography

  • 14.1. Introduction
    • 14.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 14.2. North America
    • 14.2.1. Overview
    • 14.2.2. Bioconjugation Key Manufacturers in North America
    • 14.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 14.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 14.2.5. North America Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
    • 14.2.6. North America Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
    • 14.2.7. North America Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
    • 14.2.8. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 14.2.9. North America Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 14.2.10. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 14.2.11. U.S.
      • 14.2.11.1. Overview
      • 14.2.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.2.11.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 14.2.11.4. U.S. Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 14.2.11.5. U.S. Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 14.2.11.6. U.S. Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
      • 14.2.11.7. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.2.11.8. U.S. Market Size and Forecast, By Bioconjugation Therapeutic Area, 2019 - 2032 (US$ Million)
      • 14.2.11.9. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 14.2.11.10.
    • 14.2.12. Canada
      • 14.2.12.1. Overview
      • 14.2.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.2.12.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 14.2.12.4. Canada Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 14.2.12.5. Canada Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 14.2.12.6. Canada Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
      • 14.2.12.7. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.2.12.8. Canada Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 14.2.12.9. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 14.2.12.10.
  • 14.3. Europe
    • 14.3.1. Overview
    • 14.3.2. Bioconjugation Key Manufacturers in Europe
    • 14.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 14.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 14.3.5. Europe Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
    • 14.3.6. Europe Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
    • 14.3.7. Europe Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
    • 14.3.8. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 14.3.9. Europe Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 14.3.10. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 14.3.11. Germany
      • 14.3.11.1. Overview
      • 14.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.3.11.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 14.3.11.4. Germany Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 14.3.11.5. Germany Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 14.3.11.6. Germany Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
      • 14.3.11.7. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.3.11.8. Germany Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 14.3.11.9. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 14.3.12. Italy
      • 14.3.12.1. Overview
      • 14.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.3.12.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 14.3.12.4. Italy Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 14.3.12.5. Italy Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 14.3.12.6. Italy Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
      • 14.3.12.7. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.3.12.8. Italy Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 14.3.12.9. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 14.3.13. United Kingdom
      • 14.3.13.1. Overview
      • 14.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.3.13.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 14.3.13.4. United Kingdom Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 14.3.13.5. United Kingdom Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 14.3.13.6. United Kingdom Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
      • 14.3.13.7. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.3.13.8. United Kingdom Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 14.3.13.9. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 14.3.14. France
      • 14.3.14.1. Overview
      • 14.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.3.14.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 14.3.14.4. France Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 14.3.14.5. France Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 14.3.14.6. France Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
      • 14.3.14.7. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.3.14.8. France Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 14.3.14.9. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 14.3.15. Russia
      • 14.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.3.15.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 14.3.15.3. Russia Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 14.3.15.4. Russia Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 14.3.15.5. Russia Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
      • 14.3.15.6. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.3.15.7. Russia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 14.3.15.8. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 14.3.16. Netherlands
      • 14.3.16.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.3.16.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 14.3.16.3. Netherlands Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 14.3.16.4. Netherlands Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 14.3.16.5. Netherlands Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
      • 14.3.16.6. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.3.16.7. Netherlands Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 14.3.16.8. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 14.3.17. Sweden
      • 14.3.17.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.3.17.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 14.3.17.3. Sweden Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 14.3.17.4. Sweden Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 14.3.17.5. Sweden Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
      • 14.3.17.6. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.3.17.7. Sweden Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 14.3.17.8. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 14.3.18. Poland
      • 14.3.18.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.3.18.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 14.3.18.3. Poland Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 14.3.18.4. Poland Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 14.3.18.5. Poland Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
      • 14.3.18.6. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.3.18.7. Poland Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 14.3.18.8. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 14.3.19. Rest of Europe
      • 14.3.19.1. Overview
      • 14.3.19.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.3.19.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 14.3.19.4. Rest of the Europe Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 14.3.19.5. Rest of the Europe Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 14.3.19.6. Rest of the Europe Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
      • 14.3.19.7. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.3.19.8. Rest of the Europe Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 14.3.19.9. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 14.4. Asia Pacific (APAC)
    • 14.4.1. Overview
    • 14.4.2. Bioconjugation Key Manufacturers in Asia Pacific
    • 14.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 14.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 14.4.5. Asia Pacific Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
    • 14.4.6. Asia Pacific Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
    • 14.4.7. Asia Pacific Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
    • 14.4.8. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 14.4.9. Asia Pacific Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 14.4.10. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 14.4.11. India
      • 14.4.11.1. Overview
      • 14.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.4.11.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 14.4.11.4. India Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 14.4.11.5. India Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 14.4.11.6. India Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
      • 14.4.11.7. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.4.11.8. India Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 14.4.11.9. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 14.4.12. China
      • 14.4.12.1. Overview
      • 14.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.4.12.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 14.4.12.4. China Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 14.4.12.5. China Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 14.4.12.6. China Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
      • 14.4.12.7. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.4.12.8. China Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 14.4.12.9. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 14.4.13. Japan
      • 14.4.13.1. Overview
      • 14.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.4.13.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 14.4.13.4. Japan Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 14.4.13.5. Japan Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 14.4.13.6. Japan Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
      • 14.4.13.7. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.4.13.8. Japan Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 14.4.13.9. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 14.4.14. South Korea
      • 14.4.14.1. Overview
      • 14.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.4.14.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 14.4.14.4. South Korea Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 14.4.14.5. South Korea Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 14.4.14.6. South Korea Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
      • 14.4.14.7. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.4.14.8. South Korea Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 14.4.14.9. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 14.4.15. Australia
      • 14.4.15.1. Overview
      • 14.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.4.15.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 14.4.15.4. Australia Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 14.4.15.5. Australia Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 14.4.15.6. Australia Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
      • 14.4.15.7. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.4.15.8. Australia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 14.4.15.9. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 14.4.16. Thailand
      • 14.4.16.1. Overview
      • 14.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.4.16.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 14.4.16.4. Thailand Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 14.4.16.5. Thailand Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 14.4.16.6. Thailand Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
      • 14.4.16.7. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.4.16.8. hailand Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 14.4.16.9. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 14.4.17. Indonesia
      • 14.4.17.1. Overview
      • 14.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.4.17.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 14.4.17.4. Indonesia Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 14.4.17.5. Indonesia Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 14.4.17.6. Indonesia Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
      • 14.4.17.7. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.4.17.8. Indonesia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 14.4.17.9. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 14.4.18. Philippines
      • 14.4.18.1. Overview
      • 14.4.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.4.18.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 14.4.18.4. Philippines Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 14.4.18.5. Philippines Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 14.4.18.6. Philippines Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
      • 14.4.18.7. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.4.18.8. Philippines Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 14.4.18.9. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 14.4.19. Rest of APAC
      • 14.4.19.1. Overview
      • 14.4.19.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.4.19.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 14.4.19.4. Rest of APAC Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 14.4.19.5. Rest of APAC Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 14.4.19.6. Rest of APAC Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
      • 14.4.19.7. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.4.19.8. Rest of APAC Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 14.4.19.9. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 14.5. Latin America
    • 14.5.1. Overview
    • 14.5.2. Bioconjugation Key Manufacturers in Latin America
    • 14.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 14.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 14.5.5. Latin America Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
    • 14.5.6. Latin America Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
    • 14.5.7. Latin America Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
    • 14.5.8. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 14.5.9. Latin America Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 14.5.10. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 14.5.11. Brazil
      • 14.5.11.1. Overview
      • 14.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.5.11.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 14.5.11.4. Brazil Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 14.5.11.5. Brazil Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 14.5.11.6. Brazil Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
      • 14.5.11.7. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.5.11.8. Brazil Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 14.5.11.9. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 14.5.12. Mexico
      • 14.5.12.1. Overview
      • 14.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.5.12.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 14.5.12.4. Mexico Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 14.5.12.5. Mexico Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 14.5.12.6. Mexico Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
      • 14.5.12.7. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.5.12.8. Mexico Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 14.5.12.9. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 14.5.13. Argentina
      • 14.5.13.1. Overview
      • 14.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.5.13.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 14.5.13.4. Argentina Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 14.5.13.5. Argentina Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 14.5.13.6. Argentina Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
      • 14.5.13.7. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.5.13.8. Argentina Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 14.5.13.9. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 14.5.14. Colombia
      • 14.5.14.1. Overview
      • 14.5.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.5.14.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 14.5.14.4. Colombia Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 14.5.14.5. Colombia Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 14.5.14.6. Colombia Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
      • 14.5.14.7. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.5.14.8. Colombia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 14.5.14.9. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 14.5.15. Rest of LATAM
      • 14.5.15.1. Overview
      • 14.5.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.5.15.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 14.5.15.4. Rest of LATAM Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 14.5.15.5. Rest of LATAM Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 14.5.15.6. Rest of LATAM Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
      • 14.5.15.7. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.5.15.8. Rest of LATAM Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 14.5.15.9. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 14.6. Middle East and Africa
    • 14.6.1. Overview
    • 14.6.2. Bioconjugation Key Manufacturers in Middle East and Africa
    • 14.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 14.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 14.6.5. Middle East and Africa Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
    • 14.6.6. Middle East and Africa Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
    • 14.6.7. Middle East and Africa Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
    • 14.6.8. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 14.6.9. Middle East and Africa Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 14.6.10. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 14.6.11. Saudi Arabia
      • 14.6.11.1. Overview
      • 14.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.6.11.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 14.6.11.4. Saudi Arabia Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 14.6.11.5. Saudi Arabia Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 14.6.11.6. Saudi Arabia Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
      • 14.6.11.7. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.6.11.8. Saudi Arabia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 14.6.11.9. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 14.6.12. United Arab Emirates
      • 14.6.12.1. Overview
      • 14.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.6.12.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 14.6.12.4. United Arab Emirates Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 14.6.12.5. United Arab Emirates Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 14.6.12.6. United Arab Emirates Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
      • 14.6.12.7. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.6.12.8. United Arab Emirates Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 14.6.12.9. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 14.6.13. Israel
      • 14.6.13.1. Overview
      • 14.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.6.13.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 14.6.13.4. Israel Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 14.6.13.5. Israel Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 14.6.13.6. Israel Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
      • 14.6.13.7. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.6.13.8. Israel Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 14.6.13.9. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 14.6.14. Turkey
      • 14.6.14.1. Overview
      • 14.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.6.14.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 14.6.14.4. Turkey Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 14.6.14.5. Turkey Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 14.6.14.6. Turkey Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
      • 14.6.14.7. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.6.14.8. Turkey Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 14.6.14.9. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 14.6.15. Algeria
      • 14.6.15.1. Overview
      • 14.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.6.15.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 14.6.15.4. Algeria Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 14.6.15.5. Algeria Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 14.6.15.6. Algeria Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
      • 14.6.15.7. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.6.15.8. Algeria Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 14.6.15.9. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 14.6.16. Egypt
      • 14.6.16.1. Overview
      • 14.6.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.6.16.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 14.6.16.4. Egypt Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 14.6.16.5. Egypt Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 14.6.16.6. Egypt Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
      • 14.6.16.7. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.6.16.8. Egypt Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 14.6.16.9. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 14.6.17. Rest of MEA
      • 14.6.17.1. Overview
      • 14.6.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 14.6.17.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 14.6.17.4. Rest of MEA Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 14.6.17.5. Rest of MEA Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
      • 14.6.17.6. Rest of MEA Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
      • 14.6.17.7. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 14.6.17.8. Rest of MEA Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 14.6.17.9. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

15. Key Vendor Analysis- Bioconjugation Industry

  • 15.1. Competitive Dashboard
    • 15.1.1. Competitive Benchmarking
    • 15.1.2. Competitive Positioning
  • 15.2. Company Profiles
    • 15.2.1. AbbVie Inc.
    • 15.2.2. Abcam plc
    • 15.2.3. Abzena Limited
    • 15.2.4. Agilent Technologies, Inc.
    • 15.2.5. AstraZeneca PLC
    • 15.2.6. Biocon Limited
    • 15.2.7. Bio-Techne Corporation
    • 15.2.8. Boehringer Ingelheim GmbH
    • 15.2.9. Charles River Laboratories International, Inc.
    • 15.2.10. Bristol-Myers Squibb Company
    • 15.2.11. Eli Lilly and Company
    • 15.2.12. GlaxoSmithKline plc
    • 15.2.13. F. Hoffmann-La Roche AG
    • 15.2.14. Innovagen AB
    • 15.2.15. Lonza Group AG
    • 15.2.16. Johnson & Johnson Services Inc.
    • 15.2.17. Merck KGaA
    • 15.2.18. Sanofi S.A.
    • 15.2.19. Pfizer Inc.
    • 15.2.20. Sartorius AG
    • 15.2.21. Sutro Biopharma, Inc.
    • 15.2.22. Sorrento Therapeutics, Inc.
    • 15.2.23. Thermo Fisher Scientific Inc.
    • 15.2.24. WuXi AppTec Co., Ltd.
    • 15.2.25. Others

16. 360 Degree Analyst View

17. Appendix

  • 17.1. Research Methodology
  • 17.2. References
  • 17.3. Abbreviations
  • 17.4. Disclaimer
  • 17.5. Contact Us